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Background/Aims: To report the prevalence of treatable complications (cystoid macular 
edema, CME; epiretinal membrane, ERM; and cataract) in patients with retinitis pigmentosa 
(RP).  
Methods: Consecutive RP patients attending a tertiary eye clinic in 2012. Spectral domain-
optical coherence tomography (SD-OCT) was used to determine presence of CME and ERM. 
Clinic records were reviewed to identify cataract and pseudophakia. Multivariable analyses 
adjusted for age, gender and other confounders.  
Results: Data are presented for 338 eyes from 169 patients. CME was present in 58.6% of 
patients and 50.9% of eyes, and was bilateral in 73.7%. ERM, cataract and pseudophakia 
were present in 22.8%, 23.4% and 11.2% eyes respectively. In multivariable analyses, CME 
was associated with younger age (Odds Ratio, OR 0.81, 95% Confidence Interval, CI 0.67, 
0.98) but not with gender. Patients with ERM and cataract/pseudophakia were less likely to 
also have CME (OR 0.19 95% CI 0.09, 0.40 and OR 0.37, 95% CI 0.16, 0.84, respectively). 
CME was most prevalent in patients with autosomal dominant inheritance (71.4%), followed 
by AR/sporadic inheritance (58.9%) and least likely in persons with X-linked inheritance 
(12.5%, p<0.001).  
Conclusions: The prevalence of treatable RP complications is high and suggests it may be 







Inherited retinal dystrophies are now one of the leading causes of irreversible blindness.[1] 
Retinitis pigmentosa (RP, OMIM #26800) is the most common group of inherited retinal 
disorders. Vision loss occurs through progressive loss of photoreceptors and development of 
complications such as cystoid macular edema (CME), epiretinal membrane (ERM) and 
cataract.[2] Treatment of these complications may improve vision [3-5] even if the 
underlying disorder itself continues to progress. The prevalence of complications is important 
for planning clinical trials, power calculations, and service delivery. The prevalence of CME 
has been reported from clinic based surveys to range between 11 and 20% as detected by 
fluorescein angiography,[6,7] and between 5.5 and 49% on Optical Coherence Tomography 
(OCT) [8-13].  
 
The aim of this study is to report the prevalence of CME, ERM and cataract in a hospital-
based sample of patients presenting to a tertiary eye hospital.  
 
METHODS 
This is a cross-section prevalence study of patients reviewed in the inherited retinal dystrophy 
clinics at Moorfields Eye Hospital NHS Foundation Trust, London, UK, from January 2012 
to December 2012 inclusive. The study was approved by the Human Research Ethics 
Committee of Moorfields Eye Hospital NHS Foundation Trust.   
 
Patients were included in the study if they had a consultant (MM, ATM, ARW) confirmed 
diagnosis of RP or rod cone dystrophy. The diagnosis of RP was based on a history of 
nyctalopia and evidence of peripheral visual field constriction, characteristic fundus findings 





hypoautofluoresence and central peri-macular hyperautofluorescent rings, and full field 
electroretinogram (ERG) testing in keeping with rod-cone dystrophy. ERG testing was 
performed according to the International Society for Clinical Electrophysiology of Vision 
(ISCEV) standards.[14] Inheritance pattern was determined from pedigrees and RP was 
categorised as autosomal dominant (e.g. one affected parent or child, equal gender 
distribution), autosomal recessive (e.g. no affected parents, consanguinity, simplex cases) and 
X-linked RP (e.g. males only, no male-to-male transmission, mothers may have signs). A 
limited number of patients had a molecular diagnosis. We excluded patients if they had cone 
rod dystrophy, ABCA4 retinopathy, X-linked retinoschisis, choroideremia, paraneoplastic 
retinopathy, or autoimmune retinopathy. Patients with other causes of CME such as diabetes, 
retinal vascular occlusion or uveitis were also excluded. Further details are published 
elsewhere.[15]  
 
The Spectralis HRA + OCT with viewing module version 5.1.2.0 (Heidelberg Engineering, 
Heidelberg, Germany) was used to acquire autofluorescence and SD-OCT images. The SD-
OCT protocol utilized a dense horizontal linear scan centered on the fovea which covered 
most of the macular region between the vascular arcades. The HEYEX software interface 
(version 1.6.2.0; Heidelberg Engineering) was used to view and analyzee images. OCT 
images were scrutinized for the presence of CME which was defined as the presence of 
hyporeflective cystic spaces on two or more consecutive macular raster scans. Presence of 
ERM was defined from OCT images as hyperreflectivity of the innermost retinal layer with 
or without foveal anatomical distortion. Lens status was assessed from clinical notes and 







SAS version 9.2 (SAS Institute, Cary NC) was used for analyses. Fishers’ exact test was used 
for comparing categorical variables, while the Student’s t-test and ANOVA were used for 
comparing continuous variables. Logistic regression models by subject were used to perform 
multivariable analyses adjusting for age, gender and other factors at the patient level. Results 
were considered significant at p<0.05. Odds ratios (OR) and 95% confidence intervals (CI) 
are provided.  
 
RESULTS 
There were 169 patients and 338 eyes included in this study. The mean age of patients was 
47.1 years (±18.4) (Table 1). Males comprised 46.8% of patients. The majority of patients 
had autosomal recessive/sporadic inheritance and mutations in RP1 and USH2A were the 
most common cause identified among those patients who underwent genetic testing.  
 
Table 1. Baseline characteristics of cohort 
Characteristics Number or % 
Age, years (SD) 47.1 (±18.4) 
Male (%) 46.8% 
















Unknown/not tested 95 
X-Linked (%) 8 (4.7%) 
RPGR 6 
Unknown/not tested 2 





Autosomal dominant, autosomal recessive and X-linked were determined clinically, with molecular 
confirmation in some patients.  
SD refers to standard deviation. 
 
CME was present in 58.6% of patients and 50.9% of eyes. Of these patients, 73.7% had 
bilateral CME (Table 2). ERM was present in 25.4% of patients and 22.8% of eyes, and was 
bilateral in 79.1% patients. Cataract was present in 27.2% of patients, 23.4% of eyes, and 
bilateral in 71.7% patients. Pseudophakia was present in 11.8% of patients, 11.2% of eyes, 
and was bilateral in 95% of patients. Among patients with CME, 31.3% were mild enough 
that they were not treated, 37.4% were currently being treated with oral acetazolamide, 
29.3% with topical dorzolamide, and 2% had been previously treated.  The inverse 
association with CME prevalence and age persists after controlling for inheritance pattern.  
 
Table 2. Prevalence of cystoid macular edema, epiretinal membrane and cataract  
 By patient, N (%) By Eye, N (%) 
All patients 169 338 
   
Cystoid macular edema 99 (58.6) 172 (50.9) 
Bilateral 73 (73.7) - 
Untreated 31 (31.3) 53 (30.8) 
Oral acetazolamide 37 (37.4) 68 (39.5) 
Topical dorzolamide 29 (29.3) 49 (28.5) 
Past treatment 2 (2.0) 2 (1.2) 
   
Epiretinal membrane 43 (25.4) 77 (22.8) 
Bilateral 34 (79.1) - 
   
Cataract 46 (27.2) 79 (23.4) 
Bilateral 33 (71.7) - 
   
Pseudophakia 20 (11.8) 38 (11.2) 
Bilateral 19 (95.0) - 
 
In Table 3, multivariable age-gender adjusted associations are reported. CME was associated 
with younger age (OR 0.81, 95% CI 0.67, 0.98) but not with gender. CME was most 





AR/sporadic inheritance (58.9%) and was least likely in those with X-linked inheritance 
(12.5%, p<0.001). The OR for having CME in X-linked inheritance was 0.05 95% CI 0.006, 
0.48). Patients with ERM and cataract/pseudophakia were less likely to also have CME (OR 
0.19 95% CI 0.09, 0.40 and OR 0.37, 95% CI 0.16, 0.84 respectively).  
 







Odds Ratio (95% Confidence Intervals)* 
Age, per 10 years 
increase 
0.81(0.67, 0.98) 1.13 (0.91, 1.39) 2.30 (1.68, 3.14) 
Male vs female 1.12 (0.60, 2.09) 0.99 (0.48, 2.05) 0.71 (0.32, 1.59) 
    
Inheritance pattern    
AR/sporadic 1.0 (reference) 1.0 1.0 
AD 2.00 (0.90, 4.43) 0.93 (0.40, 2.13) 0.41 (0.16, 1.10) 
XL 0.05 (0.006, 0.48)** 4.73 (0.93, 24.01) 0.38 (0.04, 3.90) 
    
Cystoid macular edema - - - 
Epiretinal membrane 0.19 (0.09, 0.40)** - - 
Cataract/pseudophakia 0.37 (0.16, 0.84)** - - 
AD refers to autosomal dominant; AR to autosomal recessive; XL to X–linked; CI to confidence 
intervals; 
* Adjusted for age. Gender was not significantly associated in any analyses.  
** Additionally adjusted for other variables significant in univariable analyses i.e.age, inheritance 
pattern, epiretinal membrane and cataract/pseudophakia. 
 
DISCUSSION 
The burden of blindness from inherited retinal dystrophies such as RP is increasing,[1] due 
partly to the lack of effective treatments for this group of disorders. A number of sight 
impairing complications are associated with RP, and vision outcome may be improved when 
these complications are identified and treated. We report that in a hospital based sample of 
169 RP patients (338 eyes), the prevalence of CME, ERM, cataract and pseudophakia in eyes 
was 50.9%, 22.8%, 23.4% and 13.6% respectively. If one eye had an RP complication, the 





prevalence of potentially treatable complications and suggests it is worthwhile screening RP 
patients, including with OCT, regularly to detect these conditions.  
 
Our prevalence findings for CME are similar to the higher estimates reported by other 
investigators. A trial of 39 patients by Adackapara et.al [8] recruited to test the efficacy of 
lutein supplements in RP reported a CME prevalence of 49% in patients (and 47% in eyes) at 
baseline. Another clinic based study by Hajali et.al [10] of consecutive patients with RP 
reported a lower CME prevalence of 38% in 124 patients, of whom 27% had bilateral CME. 
One reason for the lower prevalence reported in the study by Hajali et.al [10] may be the 
stricter definition of CME used, where more than one cystoid space was required to define 
CME. Similar studies using this definition have also reported lower prevalence of CME in 
patients, for example that by Testa et.al [16] which reported CME prevalence of 22.9%. The 
study by Testa et.al [16] excluded patients with Usher syndrome, which comprised a large 
proportion of our patients with RP and may partly contribute to the lower estimate. Other 
studies reporting lower estimates used time-domain OCT which may have missed small 
cystoid spaces due to the resolution on time domain. For example, Hagiwara et.al [9] using 
time domain OCT reported a prevalence of macular cysts as low as 5.5%. Studies using a 
similar definition to that used in our study have reported CME prevalence of 26.9% to 49%. 
[8,11]  
 
We report ERM prevalence of 22.8% among eyes in our study. A wide range of ERM 
prevalence in eyes with RP and detected using OCT has been reported, ranging from 0.6%, 
15.6%, 27.3% to 64.3%.[9,16,13,17] The highest prevalence was reported by Grigoropoulos 





account for the different estimates. Hagiwara et.al [9] reported the lowest ERM prevalence of 
0.6% using time domain OCT which is less sensitive than the SD-OCT used in our study.   
 
There are limited data on the prevalence of cataract in eyes with RP. We found 23.4% of eyes 
had cataract, while 13.6% were pseudophakic. This compares with a reported cataract and 
pseudophakia/aphakia prevalence of 36.8% and 15.4% in eyes with RP by Testa et.al [16] 
from an Italian population, and 44.4% with posterior subcapsular cataract in a Japanese 
population [18]. Rates of pseudophakia may not be directly comparable across different 
countries due to different health systems and thresholds for cataract surgery.   
 
Few studies have reported on the associations of CME. Knowledge of associations is useful 
in providing insights into the underlying pathophysiology, which remains an area of active 
research.[19] We found CME was associated with younger age, more likely in AD 
inheritance and least in X-linked inheritance, and less likely in the presence of ERM or 
cataract. That CME is less likely in older patients has been suggested,[20,21] but not 
previously demonstrated in clinical studies. A positive association with AD inheritance but 
negative with X-linked inheritance has also been reported by Sandberg et.al and Testa 
et.al,[22,16] which Hajali et. al [10] found as well, although the result was not statistically 
significant in the study of Hajali et.al [10]. Finally, Testa et.al [16] have also reported that 
CME is less likely in patients who are pseudophakic, as in our study. These results suggest 
that the pathophysiological process leading to CME in RP may differ from that leading to 
cataract and ERM, as the conditions do not appear to frequently co-exist, unlike in other 
retinal disorders such as diabetic retinopathy.[23] Our results support the hypothesis that 
relatively healthy retinal tissue is required to cause CME, for example through dysfunction of 





of RP (such as AD forms), are more likely to have CME than more severe forms (X-linked 
RP).  This would also explain the inverse association between CME and ERM as well as 
cataract, as the latter 2 conditions occur in later life, when there is less healthy retinal tissue 
remaining.       
 
Strengths of this study include its moderately large sample size, systematic evaluation of 
CME and ERM according to a pre-specified protocol, and multivariable adjustment for age 
and other confounders. Limitations include that lens status was determined from clinical 
records, with variability in documentation of cataract status. Severity and type of cataract was 
not documented. The status of pseudophakia however, is robust as this was checked from 
surgical records. We combined simplex inheritance cases with AR in our analyses, which 
may have included de novo mutations and introduced some misclassification into this 
category. This misclassification is likely to be small as the majority of simplex cases are later 
found to have AR inheritance.[2] The prevalence estimates from this study do not apply to all 
RP patients and are likely higher than the true population prevalence of RP complications. 
However, these estimates are clinically relevant as they derive from a sample of patients 
presenting to tertiary eye clinics, which is how most RP patients are managed and where 
recruitment would occur for clinical trials of new therapies. The prevalence estimates 
reported here will be of value in power calculations and trial design.     
 
In conclusion, we report that the prevalence of RP complications in a tertiary eye hospital 
setting is high, with many cases showing bilateral involvement. Younger age, AD 
inheritance, and the absence of ERM and cataract/pseudophakia were associated with 





be clinically beneficial for eye care professionals to screen RP patients with SD-OCT on a 
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